Rarer ALK fusion partners in NSCLC are TFG, KIF5B, KLC1, STRN, TPR, HIP1, GCC2, DCTN1, SQSTM1, LMO7, BIRC6, PHACTR1, and PTPN3 [44,45]. Here, ALK is linked to non-small cell lung carcinoma.